| 产品描述: | PR-619是一种非选择性的,可逆的的deubiquitinylating enzymes (DUBs)(去泛素化酶)抑制剂,EC50为1-20 μM。 |
| 靶点: |
EC50: 3.93 μM (USP4), 4.9 μM (USP8), 6.86 μM (USP7), 7.2 μM (USP2), 8.61 μM (USP5) |
| 体内研究: |
PR-619 (10 mg/kg/天) 增强顺铂对裸鼠的顺铂初治和顺铂耐药 UC 异种移植物的抗肿瘤作用。 |
| 参考文献: |
1. Altun M, et al. Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes. Chem Biol. 2011 Nov 23;18(11):1401-12. 2. Bertuccio CA, et al. Anterograde trafficking of KCa3.1 in polarized epithelia is Rab1- and Rab8-dependent and recycling endosome-independent. PLoS One. 2014 Mar 14;9(3):e92013. 3. Seiberlich V, et al. The small molecule inhibitor PR-619 of deubiquitinating enzymes affects the microtubule network and causes protein aggregate formation in neural cells: implications for neurodegenerative diseases. Biochim Biophys Acta. 2012 Nov;1823(1 4. Kuan-Lin Kuo, et al. The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo Study. Cells. 2019 Oct 17;8(10):1268. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
4.479 ml |
22.393 ml |
44.787 ml |
| 5 mM |
0.896 ml |
4.479 ml |
8.957 ml |
| 10 mM |
0.448 ml |
2.239 ml |
4.479 ml |
| 50 mM |
0.09 ml |
0.448 ml |
0.896 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |